NCT00707187View on ClinicalTrials.gov

Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2001

Primary Completion Date

July 31, 2002

Study Completion Date

July 31, 2002

Conditions
Systemic Sclerosis
Interventions
DRUG

Cialis

35 pills of study medication (20 mg)

Trial Locations (1)

08903

UMDNJ, New Brunswick

All Listed Sponsors
lead

University of Medicine and Dentistry of New Jersey

OTHER

NCT00707187 - Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction | Biotech Hunter | Biotech Hunter